1. Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom;
2. Haematology Theme Oxford Biomedical Research Centre, Oxford, United Kingdom;
3. Wellcome Trust Centre for Human Genetics and
4. The Computational Biology Research Group, Weatherall Institute of Molecular Medicine (WIMM), University of Oxford, United Kingdom;
5. Department of Internal Medicine V, University Hospital Heidelberg, Germany;
6. Clinic for Oncology, Hematology, and Palliative Medicine, Marien Hospital Düsseldorf, Germany;
7. Medical Research Council Molecular Hematology Unit, WIMM, University of Oxford, United Kingdom;
8. Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;
9. Molecular Diagnostics Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;
10. Department of Epidemiology-Biostatistics, Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY;
11. Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
12. Department of Molecular Medicine, University of Pavia, Pavia, Italy;
13. Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;
14. European Molecular Biology Laboratory Structural and Computational Biology Unit, Heidelberg, Germany;
15. Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Sweden; and
16. Department of Biochemistry and
17. Department of Pathology, University of Cambridge, Cambridge, United Kingdom